SK116599A3 - Process for the preparation of trovafloxacin salts and intermediates for the synthesis of said salts - Google Patents

Process for the preparation of trovafloxacin salts and intermediates for the synthesis of said salts Download PDF

Info

Publication number
SK116599A3
SK116599A3 SK1165-99A SK116599A SK116599A3 SK 116599 A3 SK116599 A3 SK 116599A3 SK 116599 A SK116599 A SK 116599A SK 116599 A3 SK116599 A3 SK 116599A3
Authority
SK
Slovakia
Prior art keywords
acid
compound
formula
trovafloxacin
mineral
Prior art date
Application number
SK1165-99A
Other languages
English (en)
Slovak (sk)
Inventor
Timothy Norris
Peter Robert Rose
Keith Michael Devries
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK116599A3 publication Critical patent/SK116599A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
SK1165-99A 1998-09-03 1999-08-25 Process for the preparation of trovafloxacin salts and intermediates for the synthesis of said salts SK116599A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
SK116599A3 true SK116599A3 (en) 2000-05-16

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1165-99A SK116599A3 (en) 1998-09-03 1999-08-25 Process for the preparation of trovafloxacin salts and intermediates for the synthesis of said salts

Country Status (40)

Country Link
US (1) US6359137B1 (no)
EP (1) EP0989119A1 (no)
JP (1) JP3354526B2 (no)
KR (1) KR20000022858A (no)
CN (1) CN1248580A (no)
AP (1) AP1118A (no)
AR (1) AR021475A1 (no)
AU (1) AU761035B2 (no)
BG (1) BG103703A (no)
BR (1) BR9904082A (no)
CA (1) CA2281244C (no)
CO (1) CO5251466A1 (no)
EA (1) EA002340B1 (no)
EE (1) EE04118B1 (no)
GE (1) GEP20022785B (no)
GT (1) GT199900142A (no)
HN (1) HN1999000141A (no)
HR (1) HRP990274A2 (no)
HU (1) HUP9902967A3 (no)
ID (1) ID23718A (no)
IL (1) IL131614A0 (no)
IN (1) IN191583B (no)
IS (1) IS5168A (no)
MA (1) MA24966A1 (no)
MY (1) MY130800A (no)
NO (1) NO994261L (no)
NZ (1) NZ337605A (no)
OA (1) OA11152A (no)
PA (1) PA8481001A1 (no)
PE (1) PE20001026A1 (no)
PL (1) PL335246A1 (no)
SG (1) SG74748A1 (no)
SK (1) SK116599A3 (no)
SV (1) SV1999000144A (no)
TN (1) TNSN99164A1 (no)
TR (1) TR199902138A2 (no)
TW (1) TW520369B (no)
UY (1) UY25686A1 (no)
YU (1) YU43199A (no)
ZA (1) ZA995630B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
RU2147303C1 (ru) * 1994-01-18 2000-04-10 Пфайзер Инк. Промежуточные продукты и способ получения солей нафтиридонкарбоновой кислоты
DK0789697T3 (da) * 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
PL325170A1 (en) * 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
EA002340B1 (ru) 2002-04-25
CN1248580A (zh) 2000-03-29
PA8481001A1 (es) 2000-09-29
EE9900457A (et) 2000-04-17
BG103703A (bg) 2001-08-31
IN191583B (no) 2003-12-06
CA2281244C (en) 2003-05-20
JP3354526B2 (ja) 2002-12-09
NO994261D0 (no) 1999-09-02
AU4482699A (en) 2000-03-16
IL131614A0 (en) 2001-01-28
SG74748A1 (en) 2000-08-22
HUP9902967A2 (hu) 2000-05-28
GEP20022785B (en) 2002-09-25
BR9904082A (pt) 2000-09-12
EA199900708A2 (ru) 2000-04-24
ZA995630B (en) 2001-03-01
EP0989119A1 (en) 2000-03-29
EE04118B1 (et) 2003-08-15
YU43199A (sh) 2002-11-15
CA2281244A1 (en) 2000-03-03
ID23718A (id) 2000-05-11
NZ337605A (en) 2001-03-30
SV1999000144A (es) 2000-09-05
PL335246A1 (en) 2000-03-13
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
TW520369B (en) 2003-02-11
HRP990274A2 (en) 2000-10-31
HUP9902967A3 (en) 2000-11-28
UY25686A1 (es) 2000-03-31
GT199900142A (es) 2001-02-15
TNSN99164A1 (fr) 2005-11-10
CO5251466A1 (es) 2003-02-28
HN1999000141A (es) 2000-06-19
TR199902138A2 (xx) 2000-04-21
IS5168A (is) 2000-03-04
JP2000086658A (ja) 2000-03-28
US6359137B1 (en) 2002-03-19
EA199900708A3 (ru) 2000-08-28
PE20001026A1 (es) 2000-10-11
MY130800A (en) 2007-07-31
AR021475A1 (es) 2002-07-24
HU9902967D0 (en) 1999-10-28
AP1118A (en) 2002-11-21
AP9901667A0 (en) 1999-12-31
AU761035B2 (en) 2003-05-29
NO994261L (no) 2000-03-06
MA24966A1 (fr) 2000-04-01

Similar Documents

Publication Publication Date Title
CZ402790A3 (en) Azabicycloquinolinecarboxylic acid, pharmaceutical composition containing thereof, use and intermediates for preparing said compounds
SK281941B6 (sk) Deriváty kyseliny indol-2-karboxylovej, ich použitie, spôsob ich prípravy a farmaceutický prípravok s ich obsahom
SK404391A3 (en) 3-imidazolymethyl-1,2,3,9-tetrahydro-4h-carbazole-4-on derivatives, method of their preparation and pharmaceutical agents containing this agents
CA1248532A (en) Pyrazolo¬3,4-b|pyridine derivatives and process for producing them
US6184380B1 (en) Process for preparing naphthyridones and intermediates
US5298629A (en) Intermediates in the synthesis of quinoline antibiotics
US6114531A (en) Process for preparing quinolone and naphthyridone carboxylic acids
SK116599A3 (en) Process for the preparation of trovafloxacin salts and intermediates for the synthesis of said salts
IL112323A (en) Process and intermediates for the preparation of salts of acid 7 - (1a, 5b, 6a) - (6 - amino - 3 azabicyclo [0.1.3] - hex - 3yl) - 1 - (2, 4 - difluorophenyl) - 6 - fluorine - 4,1 - Dihydro - 4 - Oxo - 1,8 - Naphthiridine - 3 - Carboxylate
EP0812838A1 (en) Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
CZ312199A3 (cs) Způsob přípravy trovafloxacinových kyselinových solí
MXPA99008100A (en) Procedure for preparing aci additional trovafloxacin salts
JP2951726B2 (ja) ピリドンカルボン酸誘導体およびその合成中間体
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US20020095043A1 (en) Process for preparing naphthyridones and intermediates
SK3899A3 (en) Process for the preparation of naphthyridones and intermediates
CZ9902648A3 (cs) Způsob výroby chinolon- a naftyridonkarboxylových kyselin
WO1996011194A1 (fr) Derive d'acide pyridonecarboxylique et intermediaire servant a effectuer sa synthese
JP2888987B2 (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩ならびにこれらの合成中間体
WO1996001260A1 (fr) Derive d'acide pyridone-carboxylique, l'un de ses esters, l'un de ses sels, et produit intermediaire pour la synthese de ces composes
MXPA99007034A (en) Procedure for preparing acids quinolone and naftiridone carboxili
JPH11255744A (ja) 2,4−二置換および2,3,5−三置換ピロール誘導体およびその製造中間体
CZ2000394A3 (cs) Specielní 3-azabicyklo[3.1.0]hexany, způsob jejich výroby a modifikace a jejich použití
CZ11999A3 (cs) Způsob výroby naftyridonů a meziprodukty
JPH1160578A (ja) ピリドンカルボン酸誘導体、そのエステルまたはこれらの塩